Skip to main content

Table 1 Clinicopathological factors according to the status of SLN in cN0 breast cancer before and after propensity score matching

From: Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1–2 and cN0 breast cancer

Factor

 

All patients (n = 582)

Matched patients (n = 178)

cN0SN− (n = 471)

cN0SN+ (n = 111)

 

cN0SN− (n = 89)

cN0SN+ (n = 89)

 

N

%

N

%

p value

N

%

N

%

p value

Age

≥ 55

150

31.8

36

32.4

0.91

34

38.2

29

32.6

0.43

< 55

321

68.2

75

67.5

 

55

61.8

60

67.4

 

T factor

T1

354

75.2

57

51.4

< 0.0001

51

57.3

51

57.3

1

T2

117

24.8

54

48.6

 

38

42.7

38

42.7

 

ER

Positive

367

77.9

92

82.9

0.24

77

86.5

77

86.5

1

Negative

104

22.1

19

17.1

 

12

13.5

12

13.5

 

PgR

Positive

320

67.9

83

74.8

0.15

64

71.9

65

73

0.87

Negative

151

22.1

28

25.2

 

25

28.1

24

27

 

HER2

Negative

390

82.8

93

83.8

0.8

79

88.8

79

88.8

1

Positive

81

17.2

18

16.2

 

10

11.2

10

11.2

 

Nuclear grade

1, 2

345

73.3

84

75.7

0.6

69

67.5

69

67.5

1

3

126

26.7

27

24.3

 

20

22.5

20

22.5

 

Ki67

≥ 14%

170

36.1

31

27.9

0.11

22

24.7

22

24.7

1

< 14%

293

63.9

77

72.1

 

67

75.3

67

75.3

 

Adjuvant chemotherapy

Yes

153

32.5

66

59.5

< 0.0001

49

55.1

49

55.1

1

No

318

67.5

45

40.5

 

40

44.9

40

44.9

 

Adjuvant radiotherapy

Yes

308

65.4

69

62.2

0.52

56

62.9

57

64

0.88

No

163

34.6

42

37.8

 

33

37.1

32

36

 
  1. ER estrogen receptor, PgR progesterone receptor, HER2 human epidermal receptor 2